Pharmacokinetic and Pharmacodynamic Profile of a Novel Phospholipid Aspirin Formulation-Reference-Cited by-同舟云学术

Pharmacokinetic and Pharmacodynamic Profile of a Novel Phospholipid Aspirin Formulation

Published:2022-01-20 Issue:4 Volume:61 Page:465-479
ISSN:0312-5963
Container-title:Clinical Pharmacokinetics
language:en
Short-container-title:Clin Pharmacokinet

Author:

Angiolillo Dominick J.^ORCID,Prats Jayne^ORCID,Deliargyris Efthymios N.,Schneider David J,Scheiman James,Kimmelstiel Carey,Steg Ph. Gabriel,Alberts Mark,Rosengart Todd,Mehran Roxana,Bhatt Deepak L.^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology

Link

https://link.springer.com/content/pdf/10.1007/s40262-021-01090-2.pdf

Reference61 articles.

1. Steinhubl SR. Historical observations on the discovery of platelets, platelet function testing and the first antiplatelet agent. Curr Drug Targets. 2011;12:1792–804.

2. Fuster V, Sweeny JM. Aspirin a historical and contemporary therapeutic overview. Circ. 2011;123:768–78.

3. Vane JR. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nat New Biol. 1971;231:232–5.

4. Antithrombotic Trialists Collaborative. Collaborative metaanalysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high-risk patients. BMJ. 2002;324:71–86.

5. Arnett DK, Blumenthal RS, Albert MA, et al. 2019 ACC/AHA guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019;140:e596–646.

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacokinetic Profile and Comparative Bioavailability of an Oral Fixed‐Dose Combination of Metformin and Acetylsalicylic Acid (Aspirin);Clinical Pharmacology in Drug Development;2024-07-22

2. Pharmacodynamic Comparison of Two Aspirin Formulations in the Caribbean: The ARC Study;Cardiology and Therapy;2024-07-15

3. Dextran-40 Reduces Partial Flap Failure: A Systematic Review and Meta-analysis for Antithrombotics after Free Flaps;Plastic and Reconstructive Surgery - Global Open;2024-05

4. Optimizing antithrombotic therapy in patients with coexisting cardiovascular and gastrointestinal disease;Nature Reviews Cardiology;2024-03-20

5. Effectiveness of buffered acetylsalicylic acid compared to other drugs in diseases patients in clinical practice: results of the CARDINAL observational retrospective study;Russian Journal of Cardiology;2023-12-20